Trials / Unknown
UnknownNCT00617474
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Labbafinejhad Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study hypothesis is that erythropoietin usage after kidney transplantation, in early phase, can improve the outcome for patients and their graft increasing patient and graft survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erythropoietin | sub cutaneous injection, 2000 unit in per injection, 3 times 1 week. |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-09-01
- Completion
- 2009-03-01
- First posted
- 2008-02-18
- Last updated
- 2008-03-28
Source: ClinicalTrials.gov record NCT00617474. Inclusion in this directory is not an endorsement.